|
⚲
|
| Keyboard |
| Smith Jeffrey Edward
✚
|
|
|---|---|
| CIK # | 0001363762 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001363762] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Interpace Biosciences Inc | |
| Smith Jeffrey Edward |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Interpace Biosciences Inc PDII
Common Stock
|
2014-11-07 | Buy | 199,800 | $1.75 | 349,650 |
|
Interpace Biosciences Inc PDII
Common Stock
|
2014-11-07 | Buy | 200 | $1.50 | 300 |
|
Interpace Biosciences Inc PDII
Common Stock
|
2014-02-25 | Grant | 31,532 | $5.13 | 161,759 |
|
Interpace Biosciences Inc PDII
Common Stock
|
2014-02-25 | Grant | 4,221 | $5.13 | 21,654 |
|
Interpace Biosciences Inc PDII
Stock Appreciation Rights · derivative
|
2014-02-25 | Grant | 88,832 | $0.00 | |
|
Interpace Biosciences Inc PDII
Stock Appreciation Rights · derivative
|
2013-04-04 | Grant | 70,850 | $0.00 | |
|
Interpace Biosciences Inc PDII
Common Stock
|
2013-04-04 | Grant | 25,660 | $5.44 | 139,590 |
|
Interpace Biosciences Inc PDII
Common Stock
|
2013-03-01 | Tax withheld | 7,310 | $7.43 | 54,313 |
|
Interpace Biosciences Inc PDII
Common Stock
|
2012-02-21 | Tax withheld | 6,367 | $7.00 | 44,569 |
|
Interpace Biosciences Inc PDII
Common Stock
|
2012-01-30 | Grant | 22,624 | $6.63 | 149,997 |
|
Interpace Biosciences Inc PDII
Stock Appreciation Rights · derivative
|
2012-01-30 | Grant | 51,546 | $0.00 |